SBIR-STTR Award

Development of Monoclonal Antibodies for the Study of Mycobacterium tuberculosis (Mtb) in the Guinea Pig
Award last edited on: 5/9/2024

Sponsored Program
SBIR
Awarding Agency
NIH : NIAID
Total Award Amount
$600,000
Award Phase
1
Solicitation Topic Code
118
Principal Investigator
Marla Popov

Company Information

GlycoScientific LLC

111 Riverbend Road
Athens, GA 30602
   (706) 352-9095
   N/A
   www.glycoscientific.com
Location: Single
Congr. District: 10
County: Clarke

Phase I

Contract Number: 75N93023C00038
Start Date: 9/1/2023    Completed: 8/31/2025
Phase I year
2023
Phase I Amount
$600,000
GlycoScientific proposes to generate antibodies specific for six inflammatory cytokines to elucidate and correlate immunological markers of tuberculosis (TB) transmission and disease development in the guinea pig. Once the antibodies are produced, the Offeror will use them to evaluate the cytokines in TB infected and non-infected guinea pigs. The production of these crucial immunological reagents will greatly enhance our understanding of basic immune responses to TB infection in naturally infected mammalian models.

Public Health Relevance Statement:
Terms:

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----